Decibel Obtains Exclusive License for ORC-13661 for Prevention of Antibiotic-related Ototoxicity
Decibel Therapeutics received worldwide, exclusive rights to develop and commercialize ORC-13661, Oricula Therapeutics’ investigational...
New Approach Against Antibiotic-resistant Bacteria in CF Patients Shows Promise in Phase 1 Trial
Researchers may have found a new way of treating antibiotic-resistant bacterial infections, specifically Pseudomonas aeruginosa, in the...
Understanding antibiotic resistance in patients with cystic fibrosis
A defective gene causes thick, sticky mucus to build up in the lungs of patients with cystic fibrosis (CF). There, it traps bacteria,...
MRSA Difficult to Eradicate, Even With Multimodal Antibiotics, CF Study Finds
Up to one month of treatment with inhaled vancomycin, the antibiotic of choice for treating most methicillin-resistant Staphylococcus...
Harmful Bacteria Replace Beneficial Ones in Gut of CF Patients, Study Finds
Cystic fibrosis (CF) patients have a higher amount of harmful gut bacteria and increased levels of intestinal inflammation than healthy...
#ECFS2018 – Multiple Sclerosis Therapy Boosts Antibiotic’s Ability to Kill Resistant P. aeruginosa S
Combining the approved multiple sclerosis treatment glatiramer acetate with the antibiotic tobramycin improved its ability to kill...
